UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 318

Sortiert nach

836 HCV ANTIVIRAL TREATMENT OUTCOMES COMPARED BETWEEN CLINICAL TRIAL PARTICIPANTS AND RECIPIENTS OF ROUTINE STANDARD OF CARE

Journal of hepatology, 2013-04, Vol.58, p.S343-S343

2013

Volltextzugriff (PDF)

End-Of-Life Healthcare Costs and Utilization among Patients with End-Stage-Liver-Disease in Ontario: A Population-Based Study

Journal of hepatology, 2016, Vol.64 (2), p.S259-S259

2016

Volltextzugriff (PDF)

Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain

Frontiers in pharmacology, 2016-09, Vol.7, p.304-304

2016

Volltextzugriff (PDF)

Why support a separate medical access framework for cannabis?

Canadian Medical Association journal (CMAJ), 2017-07, Vol.189 (28), p.E927

2017

Volltextzugriff (PDF)

The Endocannabinoid System as a Therapeutic Target in Glaucoma

Neural plasticity, 2016-01, Vol.2016, p.9364091-10

2016

Volltextzugriff (PDF)

Co-expression of the human cannabinoid receptor coding region splice variants (hCB1) affects the function of hCB1 receptor complexes

European journal of pharmacology, 2013-12, Vol.721 (1-3), p.341-354

2013

Volltextzugriff (PDF)

Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options

Neuronal signaling, 2018-12, Vol.2 (4), p.NS20170144-NS20170144

2018

Volltextzugriff (PDF)

The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients

Journal of neuroimmunology, 2014-02, Vol.267 (1), p.61-72

2014

Volltextzugriff (PDF)

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

British journal of pharmacology, 2015-10, Vol.172 (20), p.4790-4805

2015

Volltextzugriff (PDF)

Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors

British journal of pharmacology, 2019-05, Vol.176 (10), p.1455-1469

2019

Volltextzugriff (PDF)

Suppressive Actions of Betaxolol on Ionic Currents in Retinal Ganglion Cells May Explain its Neuroprotective Effects

Experimental eye research, 2000-05, Vol.70 (5), p.611-621

2000

Volltextzugriff (PDF)

THU-042 - End-Of-Life Healthcare Costs and Utilization among Patients with End-Stage-Liver-Disease in Ontario: A Population-Based Study

Journal of hepatology, 2016, Vol.64 (2), p.S259-S259

2016

Volltextzugriff (PDF)

Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons

The Journal of biological chemistry, 2014-09, Vol.289 (36), p.24845-24862

2014

Volltextzugriff (PDF)

Gesundheitsbezogener Hitzeschutz in NRW – eine Rolle des Öffentlichen Gesundheitsdienstes

Public Health Forum, 2023-12, Vol.31 (4), p.325-327

2023

Volltextzugriff (PDF)

Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment

Clinical infectious diseases, 2023-02, Vol.76 (4), p.573-581

2023

Volltextzugriff (PDF)

High-voltage-activated calcium channels in Müller cells acutely isolated from tiger salamander retina

Glia, 2005-01, Vol.49 (2), p.259-274

2005

Volltextzugriff (PDF)

Topical Analgesics for Acute Corneal Pain: Current Options and Emerging Therapeutics

Journal of cataract and refractive surgery, 2023-11, Vol.49 (11), p.1160-1167

2023

Volltextzugriff (PDF)

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

Cell, 2022-11, Vol.185 (23), p.4333-4346.e14

2022

Volltextzugriff (PDF)

PS073 - Light to Moderate Alcohol Use is not Associated with Long-Term Progression of Liver Fibrosis in Hiv Hcv Coinfected Women

Journal of hepatology, 2016, Vol.64 (2), p.S171-S172

2016

Volltextzugriff (PDF)

Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model

Neuropharmacology, 2019-06, Vol.151, p.1-12

2019

Volltextzugriff (PDF)

Bidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramers

European journal of pharmacology, 2017-10, Vol.813, p.66-83

2017

Volltextzugriff (PDF)

Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation

Molecules (Basel, Switzerland), 2020-01, Vol.25 (2), p.417

2020

Volltextzugriff (PDF)

Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy

Journal of medicinal chemistry, 2021-06, Vol.64 (12), p.8104-8126

2021

Volltextzugriff (PDF)

Rodent models of ketamine‐induced cystitis

Neurourology and urodynamics, 2021-09, Vol.40 (7), p.1704-1719

2021

Volltextzugriff (PDF)

A GPR18‐based signalling system regulates IOP in murine eye

British journal of pharmacology, 2013-06, Vol.169 (4), p.834-843

2013

Volltextzugriff (PDF)

1 – 25 von 318

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(288)
Mit Volltextzugriff
(274)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(227)
Life Sciences & Biomedicine
(203)
Animals
(109)
Humans
(103)
Male
(74)
Biological And Medical Sciences
(70)
Female
(58)
Fundamental And Applied Biological Sciences. Psychology
(41)
Rats
(35)
Medical Sciences
(33)
Mice
(32)
Pharmacology & Pharmacy
(31)
Neurosciences & Neurology
(29)
Surgery
(29)
Biochemistry & Molecular Biology
(28)
Neurosciences
(28)
Adult
(27)
Middle Aged
(25)
Cells, Cultured
(24)
Disease Models, Animal
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

836 HCV ANTIVIRAL TREATMENT OUTCOMES COMPARED BETWEEN CLINICAL TRIAL PARTICIPANTS AND RECIPIENTS OF ROUTINE STANDARD OF CARE

End-Of-Life Healthcare Costs and Utilization among Patients with End-Stage-Liver-Disease in Ontario: A Population-Based Study

Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain

Why support a separate medical access framework for cannabis?

The Endocannabinoid System as a Therapeutic Target in Glaucoma

Co-expression of the human cannabinoid receptor coding region splice variants (hCB1) affects the function of hCB1 receptor complexes

Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options

The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor

Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol‐dimethylheptyl at the type 1 and type 2 cannabinoid receptors

Suppressive Actions of Betaxolol on Ionic Currents in Retinal Ganglion Cells May Explain its Neuroprotective Effects

THU-042 - End-Of-Life Healthcare Costs and Utilization among Patients with End-Stage-Liver-Disease in Ontario: A Population-Based Study

Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons

Gesundheitsbezogener Hitzeschutz in NRW – eine Rolle des Öffentlichen Gesundheitsdienstes

Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment

High-voltage-activated calcium channels in Müller cells acutely isolated from tiger salamander retina

Topical Analgesics for Acute Corneal Pain: Current Options and Emerging Therapeutics

Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses

PS073 - Light to Moderate Alcohol Use is not Associated with Long-Term Progression of Liver Fibrosis in Hiv Hcv Coinfected Women

Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model

Bidirectional allosteric interactions between cannabinoid receptor 1 (CB1) and dopamine receptor 2 long (D2L) heterotetramers

Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation

Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma Efficacy

Rodent models of ketamine‐induced cystitis

A GPR18‐based signalling system regulates IOP in murine eye

Suchergebnisse filtern